FDA Grants Orphan Drug Designation to ACE-1334 for Scleroderma
News
The U. S. Food and Drug Administration (FDA) has granted orphan drug designation to ACE-1334, an investigational therapy that aims to ease scarring in the lungs of people with scleroderma. ... Read more